Fatty acid oxidation in the human fetus: Implications for fetal and adult disease

Journal of Inherited Metabolic Disease

Volumn 29, Issue 1, 2006, Pages 71-75

  Oey, Nadia A ^a   Ruiter, Jos P N ^b   Attié Bitach, Tania ^c   IJlst, Lodewijk ^b   Wanders, Ronald J A ^b   Wijburg, Frits A ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; ADENOSINE TRIPHOSPHATE; BUTYRYL COENZYME A DEHYDROGENASE; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID; GLUCOSE; LONG CHAIN FATTY ACID; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; MITOCHONDRIAL ENZYME;

ADULT; ADULT DISEASE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME METABOLISM; ENZYME REGULATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FETUS; FETUS DEATH; FETUS DEVELOPMENT; FETUS DISEASE; FETUS GROWTH; FETUS LIVER; FETUS MEMBRANE; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; KIDNEY PARENCHYMA; PERINATAL MORBIDITY; PREMATURITY;

ACYL-COA DEHYDROGENASE; ADENOSINE TRIPHOSPHATE; CARNITINE O-PALMITOYLTRANSFERASE; ENOYL-COA HYDRATASE; FATTY ACIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE; HUMANS; KIDNEY; LIVER; OXYGEN; PLACENTA; RNA, MESSENGER; TIME FACTORS;

EID: 33645654310     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-006-0199-x     Document Type: Article

References (33)

1. Barak Y, Liao D, He W, et al (2002) Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci USA 99: 303-308.
2. Barak Y, Nelson MC, Ong ES, et al (1999) PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4: 585-595.
3. Bartelds B, Knoester H, Smid GB, et al (2000) Perinatal changes in myocardial metabolism in lambs. Circulation 102: 926-931.
4. Berger PS, Wood PA (2004) Disrupted blastocoele formation reveals a critical developmental role for long-chain acyl-CoA dehydrogenase. Mol Genet Metab 82: 266-272.
5. Chakrapani A, Olpin S, Cleary M, Walter JH, Wraith JE, Besley GT (2000) Trifunctional protein deficiency: Three families with significant maternal hepatic dysfunction in pregnancy not associated with E474Q mutation. J Inherit Metab Dis 23: 826-834.
6. den Boer ME, Wanders RJ, Morris AA, IJlst L, Heymans HS, Wijburg FA (2002) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Clinical presentation and follow-up of 50 patients. Pediatrics 109: 99-104.
7. den Boer ME, Dionisi-Vici C, Chakrapani A, van Thuijl AO, Wanders RJ, Wijburg FA (2003) Mitochondrial trifunctional protein deficiency: A severe fatty acid oxidation disorder with cardiac and neurologic involvement. J Pediatr 142: 684-689.
8. Eaton S (2002) Control of mitochondrial beta-oxidation flux. Prog Lipid Res 41: 197-239.
9. Gluckman PD, Hanson MA (2004) Living with the past: Evolution, development, and patterns of disease. Science 305: 1733-1736.
10. Hainline BE, Kahlenbeck DJ, Grant J, Strauss AW (1993) Tissue specific and developmental expression of rat long-and medium-chain acyl-CoA dehydrogenases. Biochim Biophys Acta 1216: 460-468.
11. Hales CN, Barker DJ, Clark PM, et al (1991) Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303: 1019-1022.
12. Ibdah JA, Paul H, Zhao Y, et al (2001) Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J Clin Invest 107: 1403-1409.
13. Ijist L, Mandel H, Oostheim W, Ruiter JP, Gutman A, Wanders RJ (1998) Molecular basis of hepatic carnitine palmitoyltransferase I deficiency. J Clin Invest 102: 527-531.
14. Kerner J, Distler AM, Minkler P, Parland W, Peterman SM, Hoppel CL (2004) Phosphorylation of rat liver mitochondrial carnitine palmitoyltransferase-I: Effect on the kinetic properties of the enzyme. J Biol Chem 279: 41104-41113.
15. Lane RH, Maclennan NK, Daood MJ, et al (2003) IUGR alters postnatal rat skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1 gene expression in a fiber specific manner. Pediatr Res 53: 994-1000.
16. Lim H, Gupta RA, Ma WG, et al (1999) Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev 13: 1561-1574.
17. Oey NA, den Boer ME, Ruiter JP, et al (2003) High activity of fatty acid oxidation enzymes in human placenta: Implications for fetal-maternal disease. J Inherit Metab Dis 26: 385-392.
18. Oey NA, den Boer ME, Wijburg FA, et al (2005a) Long-chain fatty acid oxidation during early human development. Pediatr Res 57: 755-759.
19. Oey NA, Ijist L, van Roermund CW, Wijburg FA, Wanders RJ (2005b) dif-1 and colt, both implicated in early embryonic development, encode carnitine acylcarnitine translocase. Mol Genet Metab 85: 121-124.
20. Phillips DI, Barker DJ, Hales CN, Hirst S, Osmond C (1994) Thinness at birth and insulin resistance in adult life. Diabetologia 37: 150-154.
21. Prip-Buus C, Pegorier JP, Duee PH, Kohl C, Girard J (1990) Evidence that the sensitivity of carnitine palmitoyltransferase I to inhibition by malonyl-CoA is an important site of regulation of hepatic fatty acid oxidation in the fetal and newborn rabbit. Perinatal development and effects of pancreatic hormones in cultured rabbit hepatocytes. Biochem J 269: 409-415.
22. Rakheja D, Bennett MJ, Foster BM, Domiati-Saad R, Rogers BB (2002) Evidence for fatty acid oxidation in human placenta, and the relationship of fatty acid oxidation enzyme activities with gestational age. Placenta 23: 447-450.
23. Schwab KO, Ensenauer R, Matern D, et al (2003) Complete deficiency of mitochondrial trifunctional protein due to a novel mutation within the beta-subunit of the mitochondrial trifunctional protein gene leads to failure of long-chain fatty acid beta-oxidation with fatal outcome. Eur J Pediatr 162: 90-95.
24. Shekhawat P, Bennett MJ, Sadovsky Y, Nelson DM, Rakheja D, Strauss AW (2003) Human placenta metabolizes fatty acids: Implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am J Physiol Endocrinol Metab 284: E1098-E1105.
25. Simmons RA, Templeton LJ, Gertz SJ (2001) Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 50: 2279-2286.
26. Steenhout P, Elmer C, Clercx A, et al (1990) Carnitine deficiency with cardiomyopathy presenting as neonatal hydrops: Successful response to carnitine therapy. J Inherit Metab Dis 13: 69-75.
27. Tsirka AE, Gruetzmacher EM, Kelley DE, Ritov VH, Devaskar SU, Lane RH (2001) Myocardial gene expression of glucose transporter 1 and glucose transporter 4 in response to uteroplacental insufficiency in the rat. J Endocrinol 169: 373-380.
28. Tyni T, Ekholm E, Pihko H (1998) Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol 178: 603-608.
29. Tyni T, Paetau A, Strauss AW, Middleton B, Kivela T (2004) Mitochondrial fatty acid beta-oxidation in the human eye and brain: Implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res 56: 744-750.
30. van Vlies N, Tian L, Overmars H, et al (2005) Characterization of carnitine and fatty acid metabolism in the long-chain acyl-CoA dehydrogenase-deficient mouse. Biochem J 387: 185-193.
31. Wanders RJ, Ijist L, Poggi F, et al (1992) Human trifunctional protein deficiency: A new disorder of mitochondrial fatty acid beta-oxidation. Biochem Biophys Res Commun 188: 1139-1145.
32. Wanders RJ, Vreken P, den Boer ME, Wijburg FA, van Gennip AH, IJlst L (1999) Disorders of mitochondrial fatty acyl-CoA beta-oxidation. J Inherit Metab Dis 22: 442-487.
33. Yang Z, Zhao Y, Bennett MJ, Strauss AW, Ibdah JA (2002) Fetal genotypes and pregnancy outcomes in 35 families with mitochondrial trifunctional protein mutations. Am J Obstet Gynecol 187: 715-720.